Journal of Commercial Biotechnology — October 2008

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 14, Issue 4

Continuing education in biotechnology
Yali Friedman

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies
Arlen D Meyers, Donald J McCubbrey and Richard T Watson

Can compliance help marketing and business development?
John Avellanet

Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers
Laura Heinonen and Birgitta Sandberg

Got value? Determine it. Demonstrate it. Communicate it. Realise it
Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg and Shibani Pokras

Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice
Kerstin M Bode-Greuel and Klaus J Nickisch

Legal and Regulatory Update

Intellectual Property and Biotechnology: Biological Inventions
Stefan M Miller

Commercializing Successful Biomedical Technologies
Arlen D Meyers

Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences
Arlen D Meyers

Biotechnology and the Law
Edward L Korwek

Welcome to Biotech Nation
James Rogers

The Regulatory Challenge of Biotechnology
John Avellanet

Best Practices in Biotechnology Business Development
Hans-Erik Hamid Lydecker

Genetic Glass Ceilings: Transgenics for Crop Biodiversity
Drew L Kershen

Share this page

Tagged as: Journal of Commercial Biotechnology